Coronavirus and other airborne agents with pandemic potential
Autor:
Fernandez-Montero, José V.
; Soriano, Vicente
; Barreiro, Pablo
; de Mendoza, Carmen
; Artacho, Miguel Ángel
Fecha:
2020Palabra clave:
Revista / editorial:
Current opinion in environmental science and healthCitación:
Fernandez-Montero, J. V., Soriano, V., Barreiro, P., de Mendoza, C., & Artacho, M. Á. (2020). Coronavirus and other airborne agents with pandemic potential. Current opinion in environmental science & health, 17, 41-48.Tipo de Ítem:
Articulo Revista IndexadaResumen:
The recent emergence of a novel coronavirus (severe acute respiratory syndrome coronavirus 2) has caused a pandemic, which is the most severe infectious disease outbreak in many decades. Other infective agents such as influenza as well as other neglected viruses such as Lassa virus, Nipah virus or poxviruses are also a cause for concern owing to their attack rate and potential for global spread. Drug-resistant bacteria, such as Mycobacterium tuberculosis, are already a significant public health issue in many countries, and it is expected that they will be expanding in the near future. Finally, airborne bioterrorism agents have high morbidity and mortality rates and should be looked with concern in the current international unrest.
Ficheros en el ítem
Nombre: coronavirus_and_other_airborne_agents_with_pandemic_potential.pdf
Tamaño: 801.0Kb
Formato: application/pdf
Este ítem aparece en la(s) siguiente(s) colección(es)
Estadísticas de uso
| Año |
| 2012 |
| 2013 |
| 2014 |
| 2015 |
| 2016 |
| 2017 |
| 2018 |
| 2019 |
| 2020 |
| 2021 |
| 2022 |
| 2023 |
| 2024 |
| 2025 |
| Vistas |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 28 |
| 37 |
| 41 |
| 91 |
| 118 |
| Descargas |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 0 |
| 8 |
| 61 |
| 53 |
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Advances in hepatitis B therapeutics
Soriano, Vicente ; Barreiro, Pablo; Cachay, Edward R.; Kottilil, Shyamasundaran; Fernandez-Montero, José V.; Mendoza, Carmen de (Therapeutic Advances in Infectious Disease, 10/2020)Despite the availability of both effective preventive vaccines and oral antivirals, over 250 million people are chronically infected with the hepatitis B virus (HBV). Globally, chronic hepatitis B is the leading cause of ... -
Oral antivirals for the prevention and treatment of SARS-CoV-2 infection
Soriano, Vicente; de Mendoza, Carmen; Edagwa, Benson; Treviño, Ana; Barreiro, Pablo; Fernandez-Montero, José V.; Gendelman, Howard E. (AIDS Reviews, 2022)Vaccines and antivirals are the classical weapons deployed to contain, prevent, and treat life-threatening viral illnesses. Specifically, for SARS-CoV-2 infection, vaccines protect against severe COVID-19 disease manifestations ... -
Pre-exposure prophylaxis of non-HIV viral infections and the role of long-acting antivirals
Soriano, Vicente; Moreno-Torres, Víctor; de Mendoza, Carmen; Fernández-Montero, José V; Treviño, Ana; Corral, Octavio; de Jesús, Fernando; Barreiro, Pablo (AIDS Review, 2023)Viruses cause a large burden of human infectious diseases. During the past 50 years, antivirals have been developed to treat many pathogenic viruses, including herpesviruses, retroviruses, hepatitis viruses, and influenza. ...





